Noncardiogenic pulmonary edema associated with protamine administration during coronary artery bypass graft surgery

Journal of Clinical Anesthesia

Volumn 11, Issue 8, 1999, Pages 675-681

  Urdaneta, Felipe ^a   Lobato, Emilio B ^a   Kirby, Robert R ^a   Horrow, Jan C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Allergy; Anaphylaxis; Edema; Heparin; Noncardiogenic pulmonary edema; Protamine

Indexed keywords

EPTIFIBATIDE; HEPARIN; HEPARIN LYASE; HEXADIMETHRINE BROMIDE; HIRUDIN; METHYLENE BLUE; POLYCATION; PROTAMINE; PROTAMINE SULFATE; THROMBOCYTE FACTOR 4;

AGED; ANAPHYLAXIS; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS SURGERY; DRUG HYPERSENSITIVITY; FILTER; HUMAN; LUNG EDEMA; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0033383032     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(99)00120-8     Document Type: Conference Paper

References (53)

1. Sloand E.M., Kessler C.M., McIntosh C.L., Klein H.G. Methylene blue for neutralization of heparin. Thromb Res. 54:1989;677-686.
2. Weiler J.M., Freiman P., Sharath M.D., et al. Serious adverse reactions to protamine sulfate are alternatives needed? J Allergy Clin Immunol. 75:1985;297-303.
3. Horrow J.C. Protamine a review of its toxicity . Anesth Analg. 64:1985;348-361.
4. Adourian U., Shampaine E.L., Hirshman C.A., Fuchs E., Adkinson N.F. Jr. High-titer protamine-specific IgG antibody associated with anaphylaxis report of a case and quantitative analysis of antibody in vasectomized men . Anesthesiology. 78:1993;368-372.
5. Kikura M., Lee M., Levy J.H. Heparin neutralization with methylene blue, hexadimethrine, or vancomycin after cardiopulmonary bypass. Anesth Analg. 83:1996;223-227.
6. Knape J.T., Schuller J.L., de Haan P., de Jong A.P., Bovill J.G. An anaphylactic reaction to protamine in a patient allergic to fish. Anesthesiology. 55:1981;324-325.
7. Bowering J., Levy J.H. The post cardiopulmonary bypass period a systems approach . Henseley F.A. Jr, Martin D.E. A Practical Approach to Cardiac Anesthesia. 2nd ed. 1995;239-240 Little Brown and Company, Boston.
8. Kimmel S.E., Sekeres M.A., Berlin J.A., Goldberg L.R., Strom B.L. Adverse events after protamine administration in patients undergoing cardiopulmonary bypass risks and predictors of under-reporting . J Clin Epidemiol. 51:1998;1-10.
9. Sharath M.D., Metzger W.J., Richardson H.B., et al. Protamine induced fatal anaphylaxis. J Thorac Cardiovasc Surg. 90:1985;86-90.
10. Holland C.L., Singh A.K., McMaster P.R., Fang W. Adverse reactions to protamine sulfate following cardiac surgery. Clin Cardiol. 7:1984;157-162.
11. Backman S.B., Gilron I., Robbins R. Protamine-induced hypotension and bradycardia in a cardiac transplant patient. Clinical report. Can J Anaesth. 44:(5 Pt 1):1997;520-524.
12. Fairman R.P., Sessler C.N., Bierman M., Glauser F.L. Protamine sulfate causes pulmonary hypertension and edema in isolated rat lungs. J Appl Physiol. 62:1987;1363-1367.
13. Hakim T.S., Picone A., Oleary C.E., Camporesi E.M. Protamine-induced pulmonary venoconstriction in heparinized pigs. Anesth Analg. 81:1995;38-43.
14. Shapira N., Schaff H.V., Piehler J.M., White R.D., Sill J.C., Pluth J.R. Cardiovascular effects of protamine sulfate in man. J Thorac Cardiovasc Surg. 84:1982;505-514.
15. Morel D.R., Zapol W.M., Thomas S.J., et al. C5a and thromboxane generation associated with pulmonary vaso- and bronchoconstriction during protamine reversal of heparin. Anesthesiology. 66:1987;597-604.
16. Pharo G.H., Horrow J., Van Riper D.F., Levy J.H. Suspected protamine allergy diagnosis and management for coronary artery surgery . Anesth Analg. 78:1994;181-184.
17. Stewart W.J., McSweeney S.M., Kellett M.A., Faxon D.P., Ryan T.J. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation. 70:1984;788-792.
18. Takenoshita M., Sugiyama M., Okuno Y., Inagaki Y., Yoshiya I., Shimazaki Y. Anaphylactoid reaction to protamine confirmed by plasma tryptase in a diabetic patient during open heart surgery. Anesthesiology. 84:1996;233-235.
19. Metz S., Hirshman C.A. Prior vasectomy and anaphylaxis following protamine no cause and effect . Anesthesiology. 79:1993;617-619.
20. Kindler C.H., Bircher A.J., Takenoshita M. Anaphylactoid reactions to protamine. Anesthesiology. 85:1996;1209-1210. [Letter].
21. Levy J.H. The human inflammatory response. J Cardiovasc Pharmacol. 27:1996;S31-S37.
22. Horrow J.C., Pharo G.H., Levit L.S., Freeland C. Neither skin tests nor serum enzyme-linked immunosorbent assay tests provide specificity for protamine allergy. Anesth Analg. 82:1996;386-389.
23. Wakefield T.W., Lindblad B., Whitehouse W.M. Jr, Hantler C.B., Stanley J.C. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model. Surgery. 100:1986;45-51.
24. D'Ambra M. Restoration of the normal coagulation process advances in therapies to antagonize heparin . J Cardiovasc Pharmacol. 27:1996;S58-S62.
25. Michelsen L.G., Kikura M., Levy J.H., et al. Heparinase I (Neutralase) reversal of systemic anticoagulation. Anesthesiology. 85:1996;339-346.
26. Horrow J.C. Protamine a necessary evil. Ellison N., Jobes D.R. Effective Hemostasis in Cardiac Surgery. 1988;15-39 WB Saunders, Philadelphia.
27. Lowenstein E., Johnson W.E., Lappas D.G., et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology. 59:1983;470-473.
28. Culliford A.T., Thomas S., Spencer F.C. Fulminating noncardiogenic pulmonary edema a newly recognized hazard during cardiac operations . J Thorac Cardiovasc Surg. 80:1980;868-875.
29. Chang S.-W., Westcott J.Y., Henson J.E., Voelkel N.F. Pulmonary vascular injury by polycations in perfused rat lungs. J Appl Physiol. 62:1987;1932-1943.
30. Chen C.-R., Voelkel N.F., Chang S.-W. PAF potentiates protamine-induced lung edema role of pulmonary venoconstriction . J Appl Physiol. 68:1990;1059-1068.
31. Olinger G.N., Becker R.M., Bonchek L.I. Noncardiogenic pulmonary edema and peripheral vascular collapse following cardiopulmonary bypass rare protamine reaction? Ann Thorac Surg. 29:1980;20-25.
32. Horiguchi T., Enzan K., Mitsuhata H., Murata M., Suzuki M. Heparin-protamine complexes cause pulmonary hypertension in goats. Anesthesiology. 83:1995;786-791.
33. Feigenbaum H: Echocardiographic evaluation of cardiac chambers. In: Feigenbaum H (ed): Echocardiography, 5th ed. Baltimore: Williams & Wilkins, 1993:134-57.
34. Segal E., Perel A. Pulmonary edema. Kirby R.R., Gravenstein N. Clinical Anesthesia Practice. 1994;969-981 WB Saunders, Philadelphia.
35. Workshop on Assessment of Plasma Volume Expanders. Center for Biologics, Food and Drug Administration and National Heart, Lung, Blood Institute, Division of Blood Diseases and Resources. Bethesda, MD, March 25-26, 1991.
36. Schierhout G., Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients a systematic review of randomised trials . BMJ. 316:1998;961-964.
37. Kirby R.R., Downs J.B., Civetta J.M., et al. High level positive end-expiratory pressure (PEEP) in acute respiratory insufficiency. Chest. 67:1975;156-163.
38. Albert R.K. Least PEEP primum non nocere . Chest. 87:1985;2-4.
39. Hickling K.G., Henderson S.J., Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med. 16:1990;372-377.
40. Amato M.B., Barbas C.S.V., Medeiros D.M., et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 338:1998;347-354.
41. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med. 18:1992;319-321.
42. Weg J.G., Anzueto A., Balk R., et al. The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Engl J Med. 338:1998;341-346.
43. Hudson L.D. Protective ventilation for patients with acute respiratory distress syndrome. N Engl J Med. 338:1998;385-387.
44. Hoyt J.W. The shifting sands of mechanical ventilation. Crit Care Med. 26:1998;1162-1163.
45. Kirby RR: Round and round we go, and where we stop, nobody knows: the open lung concept and high-level peep (revisited). Crit Care Med (In press).
46. Weng J.T., Smith D., Graybar G., Kirby R.R. Hypotension secondary to air trapping treated with expiratory flow retard. Anesthesiology. 60:1984;350-353.
47. Dehmer G.J., Haagen D., Malloy C.R., Schmitz J.M. Anticoagulation with heparin during cardiac catheterization and its reversal by protamine. Cathet Cardiovasc Diagn. 13:1987;16-21.
48. Hashim S.W., Kay H.R., Hammond G.L., Kopf G.S., Geha A.S. Noncardiogenic pulmonary edema after cardiopulmonary bypass. Am J Surg. 147:1984;560-564.
49. Campbell F.W., Goldstein M.F., Atkins P.C. Management of the patient with protamine hypersensitivity for cardiac surgery. Anesthesiology. 61:1984;761-764.
50. Metz S., Horrow J.C., Goel I.P., Kuretu M.L., Bellwoar C. Methylene blue does not neutralize heparin after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 10:1996;474-476.
51. Montalescot G., Lowenstein E., Ogletree M.L., et al. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation. 82:1990;1765-1777.
52. DeLucia A., Wakefield T.W., Andrews P.C., et al. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal. J Vasc Surg. 18:1993;49-60.
53. Tao W., Deyo D.J., Alpard S.K., Vertrees R.A., Hoang V. Significant reduction in circuit pressure with modified plasma separation for a heparin removal device. ASAIO J. 45:1999;50-52.